Ameritas Investment Partners
ACHV icon

Ameritas Investment Partners’s Achieve Life Sciences ACHV Stock Holding History

Ameritas Investment Partners’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.1K Buy
+7,064
New +$33.7K ﹤0.01% 2305
2025
Q2 		– Sell
-3,374
Closed -$9.01K – 3199
2025
Q1 		$9.01K Hold
3,374
– – ﹤0.01% 2854
2024
Q4 		$11.9K Hold
3,374
– – ﹤0.01% 2857
2024
Q3 		$16K Hold
3,374
– – ﹤0.01% 2748
2024
Q2 		$15.9K Buy
+3,374
New +$16.3K ﹤0.01% 2718

Other funds holding ACHV

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TPG GP A
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Ameritas Investment Partners's ACHV Position: Q2 2026 in Review

Ameritas Investment Partners opened a new position in Achieve Life Sciences (ACHV) in Q2 2026: 7,064 shares worth $46.1K. The stake represents ﹤0.01% of the portfolio and ranks #2305 among its holdings. This is a return to the name: Ameritas Investment Partners previously reported a position in ACHV as recently as Q1 2025.

Ameritas Investment Partners first reported a position in ACHV in Q2 2024 and has held it in 5 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Ameritas Investment Partners held 7,064 shares of Achieve Life Sciences worth $46.1K as of Q2 2026.
  • Achieve Life Sciences was a new Ameritas Investment Partners position in Q2 2026.
  • Achieve Life Sciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2305 holding.
  • Ameritas Investment Partners first reported a position in Achieve Life Sciences in Q2 2024 and has held it in 5 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.